JSJuliana Batista da Silva

Juliana Batista da Silva

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Juliana Batista da Silva has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    18F-FES radiation dosimetry preliminary estimates for preclinical studies based on voxelized phantom

    by Andréa Vidal Ferreira, Ana Carolina Araujo Bispo, Christiane Silva Leite, Juliana Batista da Silva, Marcelo Mamede, Rodrigo Modesto Gadelha Gontijo, Bruno Melo Mendes

    Small animals, such as mice, are used in radiopharmaceutical biodistribution studies and innumerous others preclinical investigations involving ionizing radiation. Longitudinal preclinical studies with five or more image procedures, involving radiopharmaceuticals injection and/or X-radiation, are not uncommon. However, a suitable dosimetric evaluation is not always available and, sometimes, absorbed doses in animal organs or tissues and their influence in experimental results were not appropriately taken into account. Accurate calculation of absorbed doses in mice organs are needed to evaluate potential radiobiological effects that may interfere with in vivo experiments. In this work, we perform a preliminary 16α-[18F]-fluoro-17β-estradiol (18F-FES) radiation dosimetry estimates for female mice. The obtained animal dosimetric results can be useful for evaluating animal doses during the design of longitudinal preclinical studies.

  • Open Access

    Spatial resolution of a preclinical PET tomograph

    by Guilherme Cavalcante de Albuquerque Souza, Rodrigo Modesto Gadelha Gontijo, Juliana Batista da Silva, Marcelo Mamede, Andréa Vidal Ferreira

    Positron emission tomography (PET) is an important molecular image modality and its application on preclinical research has increased during last decades. Thus, in laboratory practice, it is important to implement a quality control of the equipment, since intrinsic factors influence the image quality. The objective of this work was to perform and implement spatial resolution tests for the small animal PET scanner of the Molecular Imaging Laboratory, LIM/CDTN. Empirically, spatial resolution of a PET scanner can be determined from the measurement of point or linear sources and FWHM (full width half maximum) analysis of the respective linear profiles. In this work, a point source of 22Na and a hot rod style phantom filled with 18F-FDG solution were used. Acquisition and reconstruction of images were performed with the LabPET 1.12.1 software, provided by the equipment manufacturer. Image reconstruction parameters followed the LIM standard protocol: MLEM-3D algorithm, 20 iterations, no high resolution mode, no attenuation or scatter corrections, no post-filtering. PeakFit® and Amide softwares were used to perform images post-processing. The results indicate that the scanner has an adequate spatial resolution and its value is compatible with values reported in international studies performed on similar equipments.


  • Open Access

    Synthesis and characterization of the radiopharmaceutical [18F]fluoroestradiol

    by Ana Carolina de Araujo Bispo, Leonardo Tafas Constantino Do Nascimento, Ana Clara Ferreira Castro, Lorena Assis Resende Lima, Soraya Maria Zandim Maciel Dias Ferreira, Juliana Batista da Silva, Marcelo Mamede

    [18F]Fluoroestradiol ([18F]FES), an estrogen analog, may be used in Positron Emission Tomography (PET) for evaluation of the tumor cell receptor profile in a noninvasive way, which is an important factor for determining the therapy to be used, disease staging, prognosis and response to therapy in breast cancer. [18F]FES is a new radiopharmaceutical and does not have an official monograph in any pharmacopeia until now. Therefore, the objective of this work was the optimization of the [18F]FES automatic synthesis and the elaboration of an analytical protocol for final product analyses. Initially, the synthesis of [18F]FES was performed according to a modified commercial protocol, using a TracerLab MXFDG synthesis module specific for [18F]FES synthesis. New protocols for the physicochemical quality control assays of the radiopharmaceutical were developed, including pH, chemical purity, residual solvents, radiochemical identity and purity. Physicochemical and microbiological analysis were performed with the synthesized [18F]FES at different time points to evaluate its stability. The uncorrected synthesis yield was 18.37 ± 3.07 %. All Quality Control methodologies proved to be effective for the product. The physicochemical and microbiological results obtained in the stability study showed that [18F]FES is stable during 8 hours after its synthesis, even under stress conditions. At the end of the study, it was concluded that the [18F]FES complies with all specifications required for a radiopharmaceutical intended for diagnostic use.